CYCLIN-DEPENDENT KINASE 6

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 14:49:08 UTC 2023` Edited by `admin` on `Sat Dec 16 14:49:08 UTC 2023`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	VC4EQE3CAI
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CYCLIN-DEPENDENT KINASE 6

Common Name

English

CDK-6

Common Name

English

CDK6

Common Name

English

CDKN6

Common Name

English

CELL DIVISION PROTEIN KINASE 6

Common Name

English

SERINE/THREONINE-PROTEIN KINASE PLSTIRE

Common Name

English

Code System Code Type Description

UNIPROT

Q00534

Created by admin on Sat Dec 16 14:49:09 UTC 2023 , Edited by admin on Sat Dec 16 14:49:09 UTC 2023

PRIMARY

FDA UNII

VC4EQE3CAI

Created by admin on Sat Dec 16 14:49:09 UTC 2023 , Edited by admin on Sat Dec 16 14:49:09 UTC 2023

PRIMARY

WIKIPEDIA

Cyclin-dependent kinase 6

Created by admin on Sat Dec 16 14:49:09 UTC 2023 , Edited by admin on Sat Dec 16 14:49:09 UTC 2023

PRIMARY

PHAROS

Q00534

Created by admin on Sat Dec 16 14:49:09 UTC 2023 , Edited by admin on Sat Dec 16 14:49:09 UTC 2023

PRIMARY

Related Record Type Details


					3B512HJD65

EBVACICLIB

INHIBITOR -> TARGET


					X1BF92PW9T

AT-7519

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:


					45AD6X575G

ALVOCIDIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					484EDA7KEM

N-(4-(1-CYCLOPROPYL-4-FLUORO-2-METHYL-1H-BENZO(D)IMIDAZOL-6-YL)-5-FLUOROPYRIMIDIN-2-YL)-6-(2-(DIMETHYLAMINO)ETHYL)-5,6,7,8-TETRAHYDRO-L,6-NAPHTHYRIDIN-2-AMINE

INHIBITOR -> TARGET

Interaction Type:

PRECLINICAL

Qualification:

IC50

Amount:


					276Z913G29

AZD-5438

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					ZPX6CRU43V

CIMPUCICLIB

INHIBITOR -> TARGET

Amount:


					Z6BYC0F36E

AVOTACICLIB

NON-INHIBITOR->OFF TARGET

Qualification:

IC50

Amount:


					9EK26WE8QN

RIVICICLIB

WEAK INHIBITOR->TARGET

Qualification:

IC50

Amount:


					6MC966B505

FN-1501

INHIBITOR -> TARGET


					TK8ERE8P56

RIBOCICLIB

INHIBITOR -> TARGET


					RB6Y814V4I

AMG-925

INHIBITOR -> TARGET

Amount:


					W66XP666AM

VORUCICLIB

INHIBITOR -> TARGET

Qualification:

Ki

Amount:


					U6072DO9XG

TRILACICLIB

INHIBITOR -> TARGET

Amount:


					60UAB198HK

ABEMACICLIB

INHIBITOR -> TARGET

Comments:

CELL-FREE KINASE ASSAY (CDK6/CYCLIN D1)

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					W49YFX3FPQ

Ulecaciclib

INHIBITOR -> TARGET

Amount:


					G9ZF61LE7G

PALBOCICLIB

INHIBITOR -> TARGET


					4V8ECV0NBQ

DINACICLIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					CRB7BT5JDQ

Tibremciclib

INHIBITOR -> TARGET

Amount:


					5ZHA5P4PFX

DALPICICLIB

INHIBITOR -> TARGET


					Q6460P4C0B

Inixaciclib

INHIBITOR -> TARGET

Interaction Type:

IN-VITRO, IN-VIVO

Amount:


					WBH8AY6ENB

LEROCICLIB

INHIBITOR -> TARGET

Amount:


					AX8OYB2MWW

PF-06842874

INHIBITOR -> TARGET

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL